Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use GLP-1 medications
In Study 1, we found that participants evaluated an individual who lost weight with a GLP-1 more harshly than an individual who lost weight via diet and exercise (i.e., higher in negative traits, lower in positive traits, more unhealthy, less willing to affiliate)
The variety of textures, creamy tuna, crunchy vegetables, crispy crackers, keeps eating interesting even when your appetite could not care less
In a short time, more than 100 patients contacted the site and volunteered for the study, even though they know that it is only a short safety study, not a long-term treatment for them. Jesse Cedarbaum, professor, neurologist, and clinical trialist at Yale School of Medicine, told Tides Global that current treatments mostly focus on symptoms